Pretransplant cancer in kidney recipients in relation to recurrent and de novo cancer incidence posttransplantation and implications for graft and patient survival

Background.Whether kidney transplant recipients who were treated for a malignant tumor before transplantation are at an increased risk of developing a tumor posttransplantation has not been adequately quantified and characterized.Methods.We studied more than 270 000 patients on whom pretransplant an

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Unterrainer, Christian (VerfasserIn) , Opelz, Gerhard (VerfasserIn) , Döhler, Bernd (VerfasserIn) , Süsal, Caner (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: March 2019
In: Transplantation
Year: 2019, Jahrgang: 103, Heft: 3, Pages: 581-587
ISSN:1534-6080
DOI:10.1097/TP.0000000000002459
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1097/TP.0000000000002459
Verlag, lizenzpflichtig, Volltext: insights.ovid.com
Volltext
Verfasserangaben:Christian Unterrainer, Gerhard Opelz, Bernd Döhler, Caner Süsal
Beschreibung
Zusammenfassung:Background.Whether kidney transplant recipients who were treated for a malignant tumor before transplantation are at an increased risk of developing a tumor posttransplantation has not been adequately quantified and characterized.Methods.We studied more than 270 000 patients on whom pretransplant an
Beschreibung:Gesehen am 09.03.2020
Beschreibung:Online Resource
ISSN:1534-6080
DOI:10.1097/TP.0000000000002459